Patents by Inventor Thierry Poynard

Thierry Poynard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of diagnosis of drug induced liver injury
    Patent number: 11965894
    Abstract: The present invention relates to new methods for assessing prognosis of recovery of DILI in a patient, combining measurement of serum markers through a logistic function that doesn't include bilirubin and transaminases (AST and ALT) markers.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: April 23, 2024
    Assignees: BIOPREDICTIVE, ASSISTANCE PUBLIQUE -HOPITAUX DE PARIS
    Inventor: Thierry Poynard
  • METHOD OF DIAGNOSIS OF INFECTION BY THE SARS-COV-2 VIRUS
    Publication number: 20230236197
    Abstract: The invention relates to a new non-invasive test making it possible to detect infection by the SARS-CoV-2 virus in a patient, using values of Apolipoprotein A1 alone or in combination with other markers.
    Type: Application
    Filed: May 26, 2021
    Publication date: July 27, 2023
    Inventors: Thierry POYNARD, Patrice CACOUB, Olivier DECKMYN
  • METHOD OF DIAGNOSIS OF LIVER STEATOSIS
    Publication number: 20210215718
    Abstract: The present invention relates to new methods for assessing the presence of nonalcoholic steatohepatitis (steatosis) in a patient, using functions combining biological markers without bilirubin and Body Mass Index being used as markers in the function.
    Type: Application
    Filed: July 26, 2019
    Publication date: July 15, 2021
    Inventor: Thierry POYNARD
  • METHOD OF PROGNOSIS AND FOLLOW UP OF PRIMARY LIVER CANCER
    Publication number: 20210208147
    Abstract: The present invention relates to new methods for assessing the risk of a patient, in particular with chronic liver disease, to develop primary liver cancer over time, using functions combining blood biochemical markers.
    Type: Application
    Filed: October 15, 2018
    Publication date: July 8, 2021
    Inventor: Thierry POYNARD
  • METHOD OF DIAGNOSIS OF DRUG INDUCED LIVER INJURY
    Publication number: 20200011879
    Abstract: The present invention relates to new methods for assessing prognosis of recovery of DILI in a patient, combining measurement of serum markers through a logistic function that doesn't include bilirubin and transaminases (AST and ALT) markers.
    Type: Application
    Filed: March 6, 2018
    Publication date: January 9, 2020
    Inventor: Thierry POYNARD
  • METHOD OF DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASES
    Publication number: 20190265241
    Abstract: The present invention relates to new methods for assessing NAFLD and NAH in a patient, combining measurement of serum markers through a logistic function.
    Type: Application
    Filed: September 15, 2017
    Publication date: August 29, 2019
    Inventor: Thierry POYNARD
  • Method of diagnosis of fibrotic diseases
    Patent number: 10198552
    Abstract: The present invention relates to a new diagnosis method in the field of hepatology, combining measurement of serum markers and of liver elasticity.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: February 5, 2019
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, BIOPREDICTIVE
    Inventor: Thierry Poynard
  • METHOD OF DIAGNOSIS OF FIBROTIC DISEASES
    Publication number: 20140329260
    Abstract: The present invention relates to a new diagnosis method in the field of hepatology, combining measurement of serum markers and of liver elasticity.
    Type: Application
    Filed: November 30, 2012
    Publication date: November 6, 2014
    Applicants: Assistance Publique - Hôpitaux de Paris, Biopredictive
    Inventor: Thierry Poynard
  • Diagnosis method of hepatic steatosis using biochemical markers
    Patent number: 7860656
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extent of hepatic steatosis in a patient, in particular in a patient who suffers from a disease involving hepatic steatosis, or who already had a positive diagnosis test of liver fibrosis and/or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Grant
    Filed: February 3, 2005
    Date of Patent: December 28, 2010
    Assignee: Assistance Publique-Hopitaux de Paris (Ap-Hp)
    Inventor: Thierry Poynard
  • Diagnosis method of alcoholic steato-hepatitis using biochemical markers
    Patent number: 7856319
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extent of alcoholic or non-alcoholic steato-hepatitis in a patient, in particular in a patient suffering from a disease involving alcoholic or non-alcoholic steato-hepatitis or who already had a positive diagnosis test of liver fibrosis and/or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Grant
    Filed: February 3, 2005
    Date of Patent: December 21, 2010
    Assignee: Assistance Publique-Hopitaux de Paris (Ap-Hp)
    Inventor: Thierry Poynard
  • DIAGNOSIS METHOD OF HEPATIC STEATOSIS USING BIOCHEMICAL MARKERS
    Publication number: 20090111132
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extent of hepatic steatosis in a patient, in particular in a patient who suffers from a disease involving hepatic steatosis, or who already had a positive diagnosis test of liver fibrosis and/or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Application
    Filed: February 3, 2006
    Publication date: April 30, 2009
    Inventor: Thierry Poynard
  • Diagnosis Method Of Alcoholic Or Non-Alcoholic Steato-Hepatitis Using Biochemical Markers
    Publication number: 20080145864
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extent of alcoholic or non-alcoholic steato-hepatitis in a patient, in particular in a patient suffering from a disease involving alcoholic or non-alcoholic steato-hepatitis or who already had a positive diagnosis test of liver fibrosis and/or presence of liver necroinfiammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Application
    Filed: February 3, 2006
    Publication date: June 19, 2008
    Applicant: Assistance Publique-Hopitaux de Paris
    Inventor: Thierry Poynard
  • Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
    Patent number: 7225080
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extend of a inflammatory, fibrotic or cancerous disease in a patient, in particular liver fibrosis, in particular in a patient infected with hepatitis C virus, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: May 29, 2007
    Assignee: Assistance Publique-Hopitaux de Paris (AP-HP)
    Inventor: Thierry Poynard
  • Diagnosis method of hepatic steatosis using biochemical markers
    Publication number: 20060173629
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extent of hepatic steatosis in a patient, in particular in a patient who suffers from a disease involving hepatic steatosis, or who already had a positive diagnosis test of liver fibrosis and/or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Application
    Filed: February 3, 2005
    Publication date: August 3, 2006
    Inventor: Thierry Poynard
  • Diagnosis method of alcholic or non-alcoholic steato-hepatitis using biochemical markers
    Publication number: 20060172286
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extent of alcoholic or non-alcoholic steato-hepatitis in a patient, in particular in a patient suffering from a disease involving alcoholic or non-alcoholic steato-hepatitis or who already had a positive diagnosis test of liver fibrosis and/or presence of liver necroinflammatory lesions, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Application
    Filed: February 3, 2005
    Publication date: August 3, 2006
    Inventor: Thierry Poynard
  • Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
    Publication number: 20040039553
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extend of a inflammatory, fibrotic or cancerous disease in a patient, in particular liver fibrosis, in particular in a patient infected with hepatitis C virus, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Application
    Filed: August 27, 2003
    Publication date: February 26, 2004
    Inventor: Thierry Poynard
  • Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
    Patent number: 6631330
    Abstract: The present invention is drawn to a new diagnosis method for detecting the extend of a inflammatory, fibrotic or cancerous disease in a patient, in particular liver fibrosis, in particular in a patient infected with hepatitis C virus, by using the serum concentration of easily detectable biological markers. The invention is also drawn to diagnosis kits for the implementation of the method.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: October 7, 2003
    Assignee: Assistance Publique-Hopitaux de Paris (AP-HP)
    Inventor: Thierry Poynard